RecruitingNCT06237803

European Myeloma Network (EMN) Sample Project

EMN Prospective Sample Collection Project

Sponsor

European Myeloma Network B.V.

Enrollment

6,000 participants

Start Date

Dec 21, 2022

Study Type

OBSERVATIONAL

Conditions

Multiple Myeloma Smoldering Multiple Myeloma Plasma Cell Leukemia Extramedullary Myeloma MGUS

Summary

This is an observational, non-interventional, multicenter study for the prospective collection, storage and analysis of patients' biological samples. This study establishes a common international infrastructure useful to collect standard clinical variables at baseline and during treatment and to uniformly collect and store biological samples

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting blood and tissue samples from people with plasma cell disorders — a group of conditions in which abnormal plasma cells build up in the bone marrow. The conditions range from a pre-cancer stage (MGUS) to full multiple myeloma and plasma cell leukemia. The goal is to create a sample bank to support future research into better diagnostics and treatments. **You may be eligible if...** - You are 18 or older - You have been diagnosed with MGUS (precancerous plasma cell condition), smouldering multiple myeloma, multiple myeloma, or plasma cell leukemia - You are willing and able to give written informed consent **You may NOT be eligible if...** - You have already received treatment for your plasma cell condition (with very limited exceptions) - You have had serious reactions to blood donation in the past (such as fainting or severe allergic reactions) - There are personal, social, or logistical circumstances that would prevent you from completing the study requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERstorage of biological samples

collect and store biological samples

Locations(41)

Alfred Hospital

Melbourne, Australia

KUK Linz

Linz, Austria

Medical University Vienna

Vienna, Austria

Department of Haematology UZ Leuven Gasthuisberg

Leuven, Belgium

Nemocnice Havířov

Havířov, Czechia

Nemocnice Nový Jičín

Nový Jičín, Czechia

Fakultní nemocnice

Olomouc, Czechia

Slezská nemocnice

Opava, Czechia

Fakutni nemocnice Ostrava

Ostrava, Czechia

Nemocnice Pelhrimov

Pelhřimov, Czechia

Všeobecná Fakultní nemocnice v Praz

Prague, Czechia

Regional General Hospital Alexandra Dept of Clinical Therapeutics

Athens, Greece

Theagenion Cancer Hospital

Thessaloniki, Greece

Beaumont Hospital, Dublin, Hematology Department

Galway, Ireland

A.O. 'SS. Antonio e Biagio'

Alessandria, Italy

AOU Ospedali Riuniti di Ancona

Ancona, Italy

Bari-A.O.U. Consorziale Policlinico - Medicina Interna

Bari, Italy

Policlinico S Orsola Malpighi

Bologna, Italy

A.O.Spedali Civili di Brescia

Brescia, Italy

A.S.U.R. Regione Marche

Civitanova Marche, Italy

A.O.U. Careggi

Florence, Italy

A.O.U. Policlinico S. Martino - Clinica Ematologica

Genova, Italy

A.O.U. Policlinico S. Martino - Ematologia

Genova, Italy

A.O. 'Cardinale G.Panico'

Lecce, Italy

A.O. di Rilievo Nazionale A. Cardarelli

Naples, Italy

A.O.U. Maggiore della Carità

Novara, Italy

Policlinico S. Matteo Fondazione IRCCS - Pavia

Pavia, Italy

A.O. San Camillo-Forlanini

Roma, Italy

Ospedale S. Eugenio

Roma, Italy

I.R.C.C.S. Ospedale Casa Sollievo della Sofferenza

San Giovanni Rotondo, Italy

A.O. S. Maria

Terni, Italy

A.O.U. Città della Salute e della Scienza di Torino - PO Molinette

Torino, Italy

Azienda Ospedaliera Universitaria di Udine

Udine, Italy

ULSS8 Berica Ospedale S.Bortolo

Vicenza, Italy

CHUC

Coimbra, Portugal

Fundação Champalimaud

Lisbon, Portugal

Chsj - Hosp. Sao Joao

Porto, Portugal

IPOP Porto

Porto, Portugal

Clinic of Hematology, University Clinical Center of Serbia

Belgrade, Serbia

CHUV

Lausanne, Switzerland

HOCH Health Ostschweiz Kantonsspital St.Gallen

Sankt Gallen, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06237803

Related Trials

18F-Fluciclovine PET/CT in Multiple Myeloma

NCT061038381 location

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

NCT0617988874 locations

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

NCT059471361 location

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT026826671 location

Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"

NCT048880391 location